Tvardi Therapeutics, Inc. (TVRD): Revenue
$7.14M
Year ended 2024-12-31
-32.3%
3-year compound annual growth
-18.5%
5-year compound annual growth
+8.4%
10-year compound annual growth
| Period ended | Revenue | Change YoY | Source filing |
|---|---|---|---|
| 2024-12-31 | $7.14M | -66.0% | 2025-03-11, From 2024-01-01 |
| 2023-12-31 | $20.97M | -49.9% | 2025-03-11, From 2023-01-01 |
| 2022-12-31 | $41.87M | +81.8% | 2025-03-11, From 2022-01-01 |
| 2021-12-31 | $23.03M | -83.0% | 2024-03-06, From 2021-01-01 |
| 2020-12-31 | $135.08M | +579.3% | 2023-03-06, From 2020-01-01 |
| 2019-12-31 | $19.89M | +47.6% | 2022-03-01, From 2019-01-01 |
| 2018-12-31 | $13.47M | n/m | 2021-02-25, From 2018-01-01 |
| 2017-12-31 | $911.0K | +959.3% | 2020-02-27, From 2017-01-01 |
| 2016-12-31 | $86.0K | -97.7% | 2019-03-12, From 2016-01-01 |
| 2015-12-31 | $3.80M | +19.7% | 2018-03-15, From 2015-01-01 |
| 2014-12-31 | $3.18M | -73.4% | 2017-03-10, From 2014-01-01 |
| 2013-12-31 | $11.96M | +905.4% | 2016-03-11, From 2013-01-01 |
| 2012-12-31 | $1.19M | n/a | 2015-03-27, From 2012-01-01 |